Lanfermeijer M
No ORCID on file
· 1 paper in corpus
· active 2025
Mutagenic processes and clonal selection contribute to the development of therapy-associated secondary neoplasms, a known complication of cancer treatment. The association between tamoxifen therapy and secondary uterine cancers is uncommon …